235 related articles for article (PubMed ID: 32208384)
21. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity.
Hamada J; Baasanjav A; Ono N; Murata K; Kako K; Ishida J; Fukamizu A
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H931-41. PubMed ID: 25681427
[TBL] [Abstract][Full Text] [Related]
22. Apelin and its receptor APJ in cardiovascular diseases.
Yu XH; Tang ZB; Liu LJ; Qian H; Tang SL; Zhang DW; Tian GP; Tang CK
Clin Chim Acta; 2014 Jan; 428():1-8. PubMed ID: 24055369
[TBL] [Abstract][Full Text] [Related]
23. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
[TBL] [Abstract][Full Text] [Related]
24. Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats.
Xu W; Li T; Gao L; Zheng J; Yan J; Zhang J; Shao A
J Neuroinflammation; 2019 Dec; 16(1):247. PubMed ID: 31791369
[TBL] [Abstract][Full Text] [Related]
25. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
Falcão-Pires I; Leite-Moreira AF
Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
[TBL] [Abstract][Full Text] [Related]
26. Apelin in acute myocardial infarction and heart failure induced by ischemia.
Tycinska AM; Lisowska A; Musial WJ; Sobkowicz B
Clin Chim Acta; 2012 Feb; 413(3-4):406-10. PubMed ID: 22146598
[TBL] [Abstract][Full Text] [Related]
27. Apelin-13 and APJ in paraventricular nucleus contribute to hypertension via sympathetic activation and vasopressin release in spontaneously hypertensive rats.
Zhang F; Sun HJ; Xiong XQ; Chen Q; Li YH; Kang YM; Wang JJ; Gao XY; Zhu GQ
Acta Physiol (Oxf); 2014 Sep; 212(1):17-27. PubMed ID: 24995933
[TBL] [Abstract][Full Text] [Related]
28. Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure.
Wang M; Gupta RC; Rastogi S; Kohli S; Sabbah MS; Zhang K; Mohyi P; Hogie M; Fischer Y; Sabbah HN
J Card Fail; 2013 Jul; 19(7):509-16. PubMed ID: 23834927
[TBL] [Abstract][Full Text] [Related]
29. Chronic treatment with apelin, losartan and their combination reduces myocardial infarct size and improves cardiac mechanical function.
Abbasloo E; Najafipour H; Vakili A
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):393-402. PubMed ID: 31630435
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a novel small molecule agonist scaffold for the APJ receptor.
Narayanan S; Maitra R; Deschamps JR; Bortoff K; Thomas JB; Zhang Y; Warner K; Vasukuttan V; Decker A; Runyon SP
Bioorg Med Chem; 2016 Aug; 24(16):3758-70. PubMed ID: 27369451
[TBL] [Abstract][Full Text] [Related]
31. Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia.
Rastaldo R; Cappello S; Folino A; Berta GN; Sprio AE; Losano G; Samaja M; Pagliaro P
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2308-15. PubMed ID: 21378145
[TBL] [Abstract][Full Text] [Related]
32. Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential.
Pang B; Jiang YR; Xu JY; Shao DX; Hao LY
Eur J Pharmacol; 2023 Jun; 949():175727. PubMed ID: 37062502
[TBL] [Abstract][Full Text] [Related]
33. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
Kuba K; Sato T; Imai Y; Yamaguchi T
Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
[TBL] [Abstract][Full Text] [Related]
34. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
35. Expression of the apelin-APJ pathway and effects on erectile function in a mouse model of vasculogenic erectile dysfunction.
Kwon MH; Tuvshintur B; Kim WJ; Jin HR; Yin GN; Song KM; Choi MJ; Kwon KD; Batbold D; Ryu JK; Suh JK
J Sex Med; 2013 Dec; 10(12):2928-41. PubMed ID: 23578329
[TBL] [Abstract][Full Text] [Related]
36. Apelin/APJ system: A bifunctional target for cardiac hypertrophy.
Lu L; Wu D; Li L; Chen L
Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574
[TBL] [Abstract][Full Text] [Related]
37. Apelin protects myocardial injury induced by isoproterenol in rats.
Jia YX; Pan CS; Zhang J; Geng B; Zhao J; Gerns H; Yang J; Chang JK; Tang CS; Qi YF
Regul Pept; 2006 Jan; 133(1-3):147-54. PubMed ID: 16278022
[TBL] [Abstract][Full Text] [Related]
38. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.
Szokodi I; Tavi P; Földes G; Voutilainen-Myllylä S; Ilves M; Tokola H; Pikkarainen S; Piuhola J; Rysä J; Tóth M; Ruskoaho H
Circ Res; 2002 Sep; 91(5):434-40. PubMed ID: 12215493
[TBL] [Abstract][Full Text] [Related]
39. Identification of a Hydroxypyrimidinone Compound (
Meng W; Pi Z; Brigance R; Rossi KA; Schumacher WA; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux CN; Wang T; Wexler RR; Finlay HJ
J Med Chem; 2021 Dec; 64(24):18102-18113. PubMed ID: 34855405
[TBL] [Abstract][Full Text] [Related]
40. Vascular effects of apelin: Mechanisms and therapeutic potential.
Mughal A; O'Rourke ST
Pharmacol Ther; 2018 Oct; 190():139-147. PubMed ID: 29807055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
